Publications
Treg Cells
Publication Date: December 3, 2021
Lowering the DMSO concentration in the freezing medium from 10% to 5% improved post-thaw recovery and viability of natural regulatory T cell (nTreg) products without compromising phenotype, cytokine release criteria or suppressive function. Expanded CD4+CD25+Foxp3+ Treg products were frozen in a controlled-rate freezer in human serum albumin and saline media with 5% or 10% DMSO, or a synthetic DMSO-free medium. With 5% DMSO, recovery was 73% directly after thawing and 45% at 24 h, versus 58% and 20% with 10% DMSO; 24-hour viability rose from 60% to 78%. Adding PEG, or priming cells by heat shock or paeoniflorin, gave no clear advantage. Thawed cells suppressed effector proliferation by ab…
Publications
CAR T Cells
G-Rex®6M Well Plate
Publication Date: November 17, 2021
Knocking out DNMT3A with CRISPR-Cas9 before CAR transduction kept human CAR T cells proliferating and killing through repeated antigen exposure. In weekly cocultures with U373 tumor cells at a 2:1 effector-to-target ratio with IL-15, DNMT3A knockout cells outgrew controls by 1.3-fold after the first stimulation and 22.6-fold after the fourth, and IL-10 was the only cytokine secreted differentially. Whole-genome bisulfite sequencing found more than 1600 genes with differentially methylated regions, with TCF7, LEF1 and CD28 left unmethylated in knockout cells and a higher multipotency index. Across four xenograft models the edited CAR T cells produced a survival advantage in three, and in p…
Publications
CD34 Cells, NK Cells, T-Cells
G-Rex®24 Well Plate
Publication Date: November 1, 2021
A ridged microfluidic channel that briefly compresses cells, termed volume exchange for convective transfection (VECT), delivered mRNA into human primary T cells, NK cells and CD34+ hematopoietic stem and progenitor cells (HSPCs) with high efficiency. In optimized runs, T cells reached about 80% transfection efficiency and about 70% product yield, with relative viability and recovery near 75%. NK cells reached about 60% efficiency with viability and recovery above 80%, and mobilized peripheral blood HSPCs about 75% efficiency with viability and recovery above 90%. The gap under the ridges was a critical variable. T cell efficiency held when mRNA was cut from 160 to 40 μg/ml, and transfect…
Publications
NK Cells
G-Rex®24 Well Plate
Publication Date: November 1, 2021
In a cohort of 21 patients who recovered from SARS-CoV-2 infection without intensive care or mechanical ventilation, the diversity of the natural killer (NK) cell receptor repertoire was inversely related to the rate of viral clearance. Mass cytometry measured 2.9 million live CD45+ cells, an average of 88,692 per sample, and Boolean gating on 22 NK receptors yielded 39,435 unique immunophenotypic combinations; patients with low repertoire diversity cleared virus faster after adjustment for age and sex (P = 0.033). NK subsets co-expressing DNAM1 and TIGIT were more frequent in fast clearers (slow vs. fast: 39.80% vs. 51.70%, P = 0.0114) and killed SARS-CoV-2-infected Calu-1 cells more eff…
Publications
CAR T Cells
G-Rex®100M
Publication Date: October 9, 2021
Novel CAR-T cells directed against CS1, and bispecific CS1-BCMA CAR-T cells, killed target cells expressing either antigen and suppressed multiple myeloma growth in mice. A new anti-CS1 antibody clone, 7A8D5, bound CS1 with a Kd of 5.3 nM and was used to build second-generation CARs. The bispecific cells were over 80% CAR-positive, killed CHO-CS1 and CHO-BCMA cells but not antigen-negative CHO cells, and secreted IFN-gamma against MM1S myeloma cells. Manufactured in a 1 L G-Rex® container, the bispecific cells expanded more than 180-fold in 10 days to 1.8 × 10^9 cells, mostly central memory phenotype. In NSG mice carrying MM1S tumors, CS1, BCMA and bispecific CAR-T cells reduced tumor gro…
Publications
Other
G-Rex®100
Publication Date: September 21, 2021
Human induced pluripotent stem cell (hiPSC)-derived multi-tissue organoids spontaneously formed hyaline cartilage during long-term culture in a gas-permeable G-Rex® 100 bioreactor with E8 medium alone. Cartilage was clearly recognizable by week 8 and kept a stable hyaline phenotype while growing through week 30, without mineralization or osteogenesis. The aggrecan-stained area fraction rose from 17.7% at week 8 to 57.8% at week 11 (p=0.001). Bulk RNA-seq at weeks 8, 11 and 15 linked cartilage growth to increased BMP signaling and mesoderm-formation genes, decreased neural FGF signaling, downregulated Wnt components and a significant rise in articular cartilage genes (p=0.031). Across 325…
Publications
VST Cells
Publication Date: September 8, 2021
In one healthy 42-year-old man, a single bout of graded cycling mobilized SARS-CoV-2 specific T-cells into the blood and transiently raised neutralizing antibodies, both after natural infection and after adenovirus-vector vaccination. The T-cell response to spike, membrane and nucleocapsid peptides and to the α-variant increased with exercise intensity and exceeded responses to peptides from nine other viruses. Mobilized cells proliferated more vigorously during 10-day ex vivo expansion and kept broad TCR-β diversity. Expansion was greatest for cells recognizing the membrane protein. The exercise T-cell response was 1.25-fold higher after vaccination. Infection lowered predicted peak oxyg…
Publications
VST Cells
G-Rex®10M
Publication Date: September 2, 2021
Ex vivo expanded virus-specific T cells (VSTs) produced clinical responses in 21 of 26 evaluable immunocompromised patients with adenovirus infection, 15 of them complete. Across two concurrent trials, 30 patients, 27 of them allogeneic stem cell transplant recipients, received 43 infusions between 2016 and 2019: 7 received VSTs from their own stem cell donor, 21 received partially HLA-matched third-party products and 2 received both. Quadrivalent VSTs were expanded from PBMCs stimulated with viral peptide pools and cultured for 11 to 12 days with IL-4 and IL-7. No infusion reactions were seen, and GVHD developed within 30 days of only one evaluable infusion. In vitro assays showed a main…
Publications
CAR T Cells
G-Rex®10
Publication Date: August 26, 2021
Co-electroporation of a PCR-amplified linear piggyBac transposon with mRNA encoding the hyperactive piggyBac transposase produced CD19-specific CAR T cells without any viral vector. Peripheral blood mononuclear cells from healthy donors, 1 × 10^7 per electroporation, were stimulated the next day with anti-CD3/CD28 TransAct and expanded for 21 days in IL-4, IL-7 and IL-21, with large-scale culture in G-Rex®10 flasks. Reducing the transposon dose to 0.3 µg per 100 µL yielded more than 60% CAR+ cells carrying one to three transgene copies, while high-dose plasmid electroporation reached a vector copy number near 23. Yields reached about 1 × 10^7 CAR+ cells at day 14 and about 1 × 10^8 at day…
Publications
CAR T Cells
G-Rex®24 Well Plate
Publication Date: August 24, 2021
Chimeric antigen receptors against the HLA-A*02/HPV E6 29–38 peptide complex can be optimized to approach the sensitivity and selectivity of clinical T-cell receptors in acute in vitro assays. Starting from a screen of 454 HPV peptides against six HLA alleles, the authors isolated binders from a mammalian display library and then ran light-chain and heavy-chain optimization rounds. The best CARs, CT503 and CT512, reached EC50 below 1 nM in Jurkat assays, matching the E6 TCR but about 20-fold less potent than the E7 TCR. In primary T cells, CT512 was about 10-fold less sensitive than the E6 TCR, killed HPV-positive CaSki cells, and had little effect on HPV-negative A375 cells. Changing the…
Publications
CAR T Cells
G-Rex®6 Well Plate
Publication Date: August 24, 2021
Combining the MEK inhibitor trametinib with piggyBac transposon-engineered GD2-specific CAR-T cells reduced neuroblastoma growth in xenografted mice significantly more than CAR-T cells alone. Fresh unstimulated PBMCs transfected with the GD2-CAR transgene reached 44.1% ± 6.8% CAR positivity by day 14 and were dominated by naive/stem cell memory T cells. In vitro, 10 nM trametinib blocked ERK1/2 phosphorylation, cut IFN-γ and TNF release and suppressed killing of three neuroblastoma lines, yet left CAR-T proliferation intact. In SCID Beige mice bearing GD2-high SK-N-AS tumors, 1 mg/kg oral trametinib for 7 days plus 2 × 10^6 CAR-T cells slowed growth, given simultaneously or as pretreatmen…
Publications
CD34 Cells, T-Cells
G-Rex®24 Well Plate
Publication Date: August 18, 2021
Streptavidin microbeads carrying a biotinylated Delta-like 4 Fc fusion protein (DL4-μbeads) drove stem and progenitor cells into the T-cell lineage in serum- and stromal cell-free culture. Beads of 25 μm gave 5- to 10-fold higher Notch reporter activity than other bead sizes or plate-bound DL4-Fc, and a 9:1 bead-to-cell ratio gave the most T-lineage cells from mouse progenitors. Human cord blood CD34+ cells expanded about 400-fold over 14 days, when about 70% of live hematopoietic cells were CD7+CD5+; T-cell progenitor frequency was 1 in 15 for cord blood and 1 in 172 for mobilized blood. iPSC-derived cultures produced CD3/αβTCR-expressing double-positive cells by day 42. A G-Rex® 24-well…
No manuscripts match your filters.